QuidelOrtho Executive and Leadership Team

Micah Young, the Chief Financial Officer at QuidelOrtho, directs all global financial planning, capital allocation, and investor relations strategies. Overseeing the fiscal health of the organization, the Chief Financial Officer ensures robust resource management across clinical chemistry and immunodiagnostics manufacturing divisions. This leadership role involves optimizing cost structures to support long-term investment in molecular and rapid antigen testing technologies. By maintaining rigorous financial controls, Micah Young directly impacts the company's ability to scale operations across international markets. Young manages the balance sheet to facilitate sustainable growth while mitigating risks associated with complex medical technology supply chains. Through precise financial forecasting, the Chief Financial Officer provides the necessary stability for the company to pursue aggressive research and development goals, ultimately securing the financial foundation required for continued innovation in the global diagnostics sector.

Jonathan Siegrist, the Executive VP, Research Development & Chief Technology Officer at QuidelOrtho, architects the future of diagnostic platforms and molecular testing innovation. Overseeing the entire research pipeline, the Executive VP, Research Development & Chief Technology Officer drives the development of next-generation immunodiagnostics and clinical chemistry equipment. This leadership role involves bridging the gap between scientific discovery and commercial product viability to ensure market competitiveness. By fostering collaboration between engineering teams and clinical researchers, Jonathan Siegrist accelerates the delivery of high-impact diagnostic tools to healthcare providers worldwide. Siegrist manages the technical roadmap to align with evolving medical standards and patient care requirements. Through the integration of advanced molecular technologies, the Executive VP, Research Development & Chief Technology Officer maintains the company's position at the forefront of the medical technology industry, consistently pushing boundaries to enhance diagnostic accuracy and operational efficiency for clinical laboratories.

Philip McLellan, the Chief Operations Officer at QuidelOrtho, manages the global manufacturing footprint and supply chain logistics for clinical chemistry and transfusion medicine products. Overseeing daily production cycles, the Chief Operations Officer ensures seamless delivery of rapid antigen and molecular testing equipment to diverse healthcare markets. This leadership role involves optimizing manufacturing processes to maintain high quality standards while meeting fluctuating global demand. By streamlining operational workflows, Philip McLellan directly impacts the efficiency of the company's distribution networks across North America and international regions. McLellan coordinates with cross-functional teams to resolve logistical bottlenecks and enhance production capacity. Through the implementation of lean manufacturing principles, the Chief Operations Officer drives operational excellence, ensuring that the company consistently provides reliable diagnostic solutions to hospitals and laboratories, thereby supporting the critical infrastructure of the global healthcare system.

Nathaniel Sisitsky, the Chief Legal Officer at QuidelOrtho, directs all corporate governance, regulatory compliance, and intellectual property strategies. Overseeing the legal framework for the company's diverse portfolio of medical devices, the Chief Legal Officer ensures adherence to international health regulations and manufacturing standards. This leadership role involves managing complex litigation, contract negotiations, and strategic partnerships that define the company's market presence. By protecting the intellectual property associated with proprietary immunodiagnostics and molecular testing, Nathaniel Sisitsky secures the company's competitive advantage in the medical technology landscape. Sisitsky provides critical guidance to the Board and executive leadership regarding risk management and ethical business practices. Through the oversight of global regulatory filings, the Chief Legal Officer facilitates the expansion of product reach into new territories, ensuring that all operations align with legal requirements while supporting the company's mission to deliver life-saving diagnostic technology.